Dietary supplementation with astaxanthin enhances anti-tumor immune response and aids the enhancement of molecularly targeted therapy for hepatocellular carcinoma
Pengfei Ren, Xinyue Yu, Han Yue, Qingjuan Tang, Yuming Wang, Changhu Xue
Abstract
. The findings of these studies indicate that astaxanthin has the potential to augment the immune response against tumors when used in conjunction with sorafenib. These studies offer a novel framework for the advancement of astaxanthin as an immunomodulatory agent and a dietary supplement for individuals with tumors.
Topics & Concepts
Hepatocellular carcinomaAstaxanthinImmune systemCancer researchMedicineTargeted therapyOncologyPharmacologyInternal medicineFood scienceChemistryImmunologyCancerCarotenoidCancer, Hypoxia, and MetabolismAntioxidant Activity and Oxidative StressCancer Research and Treatments